1) programma di ricerca
Hepatitis C Virus HCV - A Phase IV Trial of Paritaprevir/Ritonavir, Ombitasvir, Dasabuvir for Chronic Hepatitis C Genotype 1 Virus Infection (D3FEAT)
leader del programma
2) programma di ricerca
Statoepatite non alcolica NASH - Phase 2b Study in NASH to Assess IVA337 (NATIVE)
leader del programma
3) programma di ricerca
Emocromatosi ereditaria - A Two-year Study to Evaluate the Efficacy and Safety of Deferasirox Film-coated Tablet Versus Phlebotomy in Patients With Hereditary Hemochromatosis
leader del programma
4) programma di ricerca
Statoepatite non alcolica NASH - Safety, Tolerability, and Efficacy of a Combination Treatment of Tropifexor (LJN452) and Cenicriviroc (CVC) in Adult Patients With Nonalcoholic Steatohepatitis (NASH) and Liver Fibrosis (TANDEM)
leader del programma
5) programma di ricerca
Statoepatite non alcolica NASH - Safety, Tolerability, Pharmacokinetics and Efficacy of LMB763 in Patients With NASH
leader del programma
6) programma di ricerca
Epatite autoimmune - ADCC Mediated B-Cell dEpletion and BAFF-R Blockade (AMBER)
leader del programma
7) programma di ricerca
Hepatitis C Virus HCV - Randomised Study of Interferon-free Treatment for Recently Acquired Hepatitis C in PWID and People With HIV Coinfection (REACT)
leader del programma
8) programma di ricerca
Non-alcoholic Statohepatitis NASH - Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment (REGENERATE)
leader del programma
9) programma di ricerca
Statoepatite non alcolica NASH - Safety and Efficacy of Selonsertib in Adults With Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis (STELLAR 3)
leader del programma
10) programma di ricerca
Statoepatite non alcolica NASH - Safety and Efficacy of Selonsertib in Adults With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) (STELLAR 4)
leader del programma
11) programma di ricerca
Trapianto - Reducing the Burden of Influenza after Solid-Organ Transplantation: the STOP-FLU trial [Swiss Trial in solid Organ transplantation on Prevention of inFLUenza]
leader del programma